Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Sartans Market Set To Climb From $23.09 Billion In 2026 To $27.13 Billion By 2030
The sartans market size has experienced consistent expansion in recent years. This market is projected to grow from $22.18 billion in 2025 to $23.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.1%. The historic period’s growth can be linked to factors like the high global hypertension prevalence, the burden of cardiovascular disease, generic drug adoption, hospital-based prescribing, and the long-term safety profile of sartans.
The sartans market is anticipated to show steady expansion in the coming years, growing to $27.14 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. This projected growth during the forecast period is fueled by an aging population, an increasing incidence of kidney disease, the demand for cost-effective therapeutic options, the expansion of outpatient treatment services, and the rise of digital pharmacies. Significant trends for the forecast period include the growing utilization in hypertension management, the proliferation of generic angiotensin receptor blockers, a preference for combination cardiovascular therapies, the broadening reach of online pharmacy distribution, and a concentrated focus on renal and cardiovascular protection.
Get A Free Sample Report With In-Depth Market Insights:
Sartans Market Growth Factors Behind Sustained Expansion
The expanding prevalence of hypertension is projected to stimulate the growth of the sartans market. Hypertension is characterized by persistently elevated blood pressure, which can heighten the risk of heart disease, stroke, and other severe health complications. The rising occurrence of this condition is linked to diets abundant in salt and processed foods, contributing to fluid retention and increased cardiac strain. Sartans function by treating hypertension through the blockade of angiotensin II, a hormone known to narrow blood vessels. This mechanism aids in relaxing and widening these vessels, which in turn lowers blood pressure and reduces the heart’s workload. For example, in September 2025, data from the World Health Organization, a Switzerland-based international public health agency, indicated that an estimated 1.4 billion adults aged 30–79 years worldwide were living with hypertension in 2024, representing approximately 33% of the global population. Therefore, the increasing prevalence of hypertension is a key driver for the expansion of the sartans market.
Sartans Market Segment Outlook: Which Categories Are Growing Fastest?
The sartans market covered in this report is segmented –
1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
4) By End-User: Hospitals, Other End-Users
Subsegments:
1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations
2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules
3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets
4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs
5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets
6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets
Sartans Market Industry Trends Fueling Future Revenue Growth
Companies prominent in the sartans market are concentrating on developing advanced products, such as tablet-form sartans, to improve treatment efficacy and patient adherence. These tablet-form sartans are oral medications containing sartan drugs, which function by blocking the effects of angiotensin II, thereby promoting blood vessel relaxation and reducing blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, obtained US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are sold under the brand name Diovan. These tablets are prescribed for treating hypertension and heart failure, and to enhance survival after a heart attack in adults, while also being suitable for pediatric patients aged one year and older.
Sartans Market Leading Companies And Competitive Benchmarking
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.
View The Full Sartans Market Report:
Sartans Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model